Skip to main content
. 2024 Feb 28;8(8):1846–1856. doi: 10.1182/bloodadvances.2023012408

Figure 2.

Figure 2.

Measured C-trough DOAC levels assessed at steady-state in atrial fibrillation patients who experienced thrombotic outcomes within 1 year follow-up. Blue dots represent the values and dotted lines represent the mean values of each drug.